Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02591433

JeffQuit Group Therapy Program for Smoking Cessation in Patients With a History of Cancer

Pilot Study of the Effectiveness of the JeffQuit Smoking Cessation Program

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot clinical trial studies how well the "JeffQuit" group therapy program works in enabling patients with a history of cancer to quit smoking. The JeffQuit program uses group therapy to provide psychological support and address the mental need for smoking, the habit or routine it creates, and the physical need for nicotine. It is not yet known how well the JeffQuit program will work in helping patients with a history of cancer to stop smoking.

Detailed description

PRIMARY OBJECTIVES: I. To assess the initial effectiveness of the JeffQuit program on smoking cessation in cancer patients. II. To assess the quality of life improvements related to the JeffQuit smoking cessation program in cancer patients. OUTLINE: Patients undergo three, 1-hour group therapy sessions held by a JeffQuit practitioner over a 1-month period. Patients receive strategies for managing the psychological, habitual, and physiological components of smoking and help with developing a planned quit date. Patients are also provided with advice on how to switch to cigarette brands with less nicotine and then how to substitute the nicotine patch and gum for cigarettes. The JeffQuit counselor is available for additional individual support as needed. After completion of study, patients are followed up at 6 months.

Conditions

Interventions

TypeNameDescription
OTHERTobacco Cessation CounselingUndergo JeffQuit group therapy
OTHERSupport Group TherapyUndergo JeffQuit group therapy
OTHERQuality-of-Life AssessmentAncillary studies

Timeline

Start date
2013-08-01
Primary completion
2014-11-01
First posted
2015-10-29
Last updated
2025-05-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02591433. Inclusion in this directory is not an endorsement.